Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men
Clinical trial NCT02716675 · COMPLETED
Trial details
- NCT number
- NCT02716675
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-06
- Primary completion
- 2020-12-01
- Enrollment
- 2699
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.